Quantum-Si Incorporated (NASDAQ:QSI – Get Free Report) saw some unusual options trading activity on Thursday. Investors acquired 20,554 call options on the company. This represents an increase of approximately 1,021% compared to the average volume of 1,834 call options.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings downgraded Quantum-Si from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Quantum-Si currently has an average rating of “Reduce” and a consensus price target of $1.00.
View Our Latest Analysis on Quantum-Si
Quantum-Si Price Performance
Institutional Investors Weigh In On Quantum-Si
A number of hedge funds have recently bought and sold shares of the business. Green Alpha Advisors LLC acquired a new position in shares of Quantum-Si in the 2nd quarter valued at approximately $41,000. Renaissance Technologies LLC bought a new stake in shares of Quantum-Si in the first quarter worth $91,000. Hollencrest Capital Management increased its stake in shares of Quantum-Si by 301.1% in the first quarter. Hollencrest Capital Management now owns 40,111 shares of the company’s stock worth $31,000 after buying an additional 30,111 shares during the last quarter. Virtu Financial LLC acquired a new stake in Quantum-Si in the fourth quarter valued at $262,000. Finally, Invesco Ltd. raised its holdings in Quantum-Si by 36.2% in the fourth quarter. Invesco Ltd. now owns 402,821 shares of the company’s stock valued at $443,000 after acquiring an additional 107,093 shares in the last quarter. Institutional investors and hedge funds own 39.90% of the company’s stock.
About Quantum-Si
Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.
Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.
See Also
- Five stocks we like better than Quantum-Si
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.
